Kathmandu Metropolis: 90 Women Test Positive for HPV DNA in Cancer Screening
Kathmandu. In Kathmandu Metropolis, out of 2,779 women tested for breast and cervical cancer, 90 showed a positive HPV DNA report.
In collaboration with Bir Hospital, Kathmandu Metropolitan City conducted free breast and cervical cancer screening for women from Chaitra 16, 2082 to Baishakh 21, 2083. The laboratory report showed 12 individuals positive for HPV 16, 13 for HPV 18, and 65 for HPV other than 16 and 18.
Infection with HPV 6, HPV 11, HPV 16, HPV 18, HPV 31, HPV 33, HPV 45, HPV 52, and HPV 58 poses a risk of cancer. Among these, only HPV 16 and HPV 18 were tested in Nepal. This year, the metropolis also tested for HPV types other than HPV 16 and 18.
An HPV DNA positive result does not mean cancer. It indicates a risk of developing cancer due to infection.
Within the 35-day screening period, 3,494 individuals registered at the Health Promotion Center and obtained referral slips. Of these, only 2,975 reached the hospital for screening. According to Chandra Bhatta, the program's focal person, among those who underwent screening, 2,779 were tested for HPV, and 2,961 for breast cancer. Of these, 411 underwent mammograms, and 494 had breast ultrasounds.
Among them, 4 required breast biopsies. 1 did not follow up. 2 tested positive and are currently undergoing treatment. 1 had a breast lump detected.
11 individuals were diagnosed with CIN, or Cervical Intraepithelial Neoplasia, a precancerous condition. This condition has three grades: CIN One, CIN Two, and CIN Three. Among the 11, 4 had high-grade issues and 7 had low-grade issues.
2 individuals underwent cervical polypectomy to remove growths from the cervix. During the screening, women with uterine prolapse and cervical infections (PID) were also treated.
This specific news has been automatically translated by AI. As a result, there may be some inaccuracies or language errors.
